Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours Β· Estimated delivery Oct 25 - Oct 30
We do not recommend B12 injections while pregnant or breastfeeding
Retatrutide is a triple-receptor agonist peptide studied in metabolic research for its simultaneous activation of GLP-1, GIP, and glucagon receptors , making it the most advanced multi-pathway metabolic research compound currently available and representing the next generation beyond dual-receptor peptides like Tirzepatide and Semaglutide
You can experience positive changes in the first three months of treatment
Metabolic balance: B12 supports carbohydrate and fat metabolism that NAD+ enhances through coenzyme activity
Most research has focused on semaglutides ability to help manage blood sugar levels and reduce body weight
US$ 21.88
US$ 28.19
US$ 20.97
US$ 27.86
US$ 29.27
US$ 20.23
US$ 28.47
US$ 22.21
US$ 20.89
